Universidad Peruana Cayetano Heredia

Listar por autor "Granger, Christopher B."

Listar por autor "Granger, Christopher B."

Ordenar por:Orden:Resultados:

  • Antithrombotic Therapy in Patients with Atrial Fibrillation and Acute Coronary Syndrome Treated Medically or with Percutaneous Coronary Intervention or Undergoing Elective Percutaneous Coronary Intervention: Insights from the AUGUSTUS Trial. 
    Windecker, Stephan; Lopes, Renato D.; Massaro, Tyler; Jones-Burton, Charlotte; Granger, Christopher B.; Aronson, Ronald; Heizer, Gretchen; Goodman, Shaun G.; Darius, Harald; Jones, W. Schuyler; Aschermann, Michael; Brieger, David; Cura, Fernando; Engstrom, Thomas; Fridrich, Viliam; Halvorsen, Sigrun; Huber, Kurt; Kang, Hyun-Jae; Leiva-Pons, Jose L.; Lewis, Basil S.; Málaga Rodríguez, Germán Javier; Meneveau, Nicolas; Merkely, Bela; Milicic, Davor; Morais, Joao; Potpara, Tatjana S.; Raev, Dimitar; Sabate, Manel; de Waha-Thiele, Suzanne; Welsh, Robert C.; Xavier, Denis; Mehran, Roxana; Alexander, John H. (Wolters Kluwer Health, 2019)
    Background: The safety and efficacy of antithrombotic regimens may differ between patients with atrial fibrillation (AF) who have acute coronary syndromes (ACS), treated medically or with percutaneous coronary intervention ...
  • Morphine and clinical outcomes in patients with ST segment elevation myocardial infarction treated with fibrinolytic and antiplatelet therapy: Insights from the TREAT trial 
    Cantor, Warren J.; Tan, Mary; Berwanger, Otavio; Lavi, Shahar; White, Harvey D.; Nicolau, Jose C.; Dehghani, Payam; Tajer, Carlos D.; Lopes, Renato D.; Moia, Diogo D. F.; Nicholls, Stephen J.; Parkhomenko, Alexander; Averkov, Oleg; Brass, Neil; Lutchmedial, Sohrab; Málaga Rodríguez, Germán Javier; Damiani, Lucas P.; Piegas, Leopoldo S.; Granger, Christopher B.; Goodman, Shaun G. (Elsevier, 2022)
    Background: Morphine is commonly used to relieve pain, anxiety and dyspnea in STEMI but it lowers blood pressure and delays the activity of oral antiplatelet agents. The impact of morphine on clinical outcomes remains ...
  • Ticagrelor Versus Clopidogrel in Patients With STEMI Treated With Fibrinolysis: TREAT Trial 
    Berwanger, Otavio; Lopes, Renato D.; Moia, Diogo D. F.; Fonseca, Francisco A.; Jiang, Lixin; Goodman, Shaun G.; Nicholls, Stephen J.; Parkhomenko, Alexander; Averkov, Oleg; Tajer, Carlos; Málaga Rodríguez, Germán Javier; Saraiva, Jose F. K.; Guimaraes, Helio P.; de Barros E Silva, Pedro G. M.; Damiani, Lucas P.; Santos, Renato H. N.; Paisani, Denise M.; Miranda, Tamiris A.; Valeis, Nanci; Piegas, Leopoldo S.; Granger, Christopher B.; White, Harvey D.; Nicolau, Jose C. (Elsevier, 2019)
    Background: The efficacy of ticagrelor in the long-term post–ST-segment elevation myocardial infarction (STEMI)treated with fibrinolytic therapy remains uncertain. Objectives: The purpose of this study was to evaluate the ...
  • Ticagrelor vs Clopidogrel After Fibrinolytic Therapy in Patients With ST-Elevation Myocardial Infarction: A Randomized Clinical Trial 
    Berwanger, Otavio; Nicolau, Jose C.; Carvalho, Antonio C.; Jiang, Lixin; Goodman, Shaun G.; Nicholls, Stephen J.; Parkhomenko, Alexander; Averkov, Oleg; Tajer, Carlos; Málaga Rodríguez, Germán Javier; Saraiva, Jose F. K.; Fonseca, Francisco A.; De Luca, Fábio A.; Guimaraes, Helio P.; de Barros E Silva, Pedro G. M.; Damiani, Lucas P.; Paisani, Denise M.; Lasagno, Camila M. R.; Candido, Carolina T.; Valeis, Nanci; Moia, Diogo D. F.; Piegas, Leopoldo S.; Granger, Christopher B.; White, Harvey D.; Lopes, Renato D.; TREAT Study Group (American Medical Association, 2018)
    Importance: The bleeding safety of ticagrelor in patients with ST-elevation myocardial infarction treated with fibrinolytic therapy remains uncertain. Objective: To evaluate the short-term safety of ticagrelor when compared ...

Buscar en el Repositorio

Listar

Panel de Control